Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04226326 · ClinicalTrials.gov registry record · NA
Investigating the Utility of Remote Index of Microvascular Resistance in Patients With Chronic Total Occlusion
A NA study of Chronic Total Occlusion, sponsored by University of Chicago.
- Completed
- Registry status
- NA
- Development phase
- 4
- Enrollment target
- 1
- Study location
NCT04226326 is a NA study of Chronic Total Occlusion that has completed, run by University of Chicago. The registered enrollment target is 4 participants. The trial reports 1 study location across 1 state.
The verdict
NCT04226326, a NA study of Chronic Total Occlusion, has completed, sponsored by University of Chicago.
- COMPLETED
- Registry status
- NA
- Development phase
- 4 participants
- Enrollment target
- 1
- Study location
Study Summary
This is prospective cohort study in subjects with a planned percutaneous coronary intervention (PCI) of their chronic total occlusion (CTO). The study will enroll subjects who have been scheduled for a clinically-indicated cardiac catheterization, and will evaluate coronary microvascular function in all subjects meeting inclusion criteria with a coronary flow wire. Evaluation of coronary microvascular function may be performed using indirect methods, however the rationale behind the present study is to directly measure microvascular function using direct coronary flow measurements, since the subjects in the study are to undergo a clinically-indicated cardiac catheterization. The overall purpose of the study is to define the presence and severity of coronary microvascular dysfunction subjects with CTO. The study is designed to enroll 50 subjects with CTO in the span of 3 years. There will be a 6-month assessment of the outcomes of death and cardiovascular death. As the study includes FDA approved tests, there will be no safety endpoint per se, however there will be a mechanism for monitoring adverse events as will be described in detail.
Conditions Studied
Interventions
- OTHER Directly measure microvascular function using direct coronary flow measurements
Study Locations (1)
Illinois
- University of Chicago Medical Center - Chicago
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 4 participants |
| Start Date | 2020-01-15 |
| Est. Completion | 2023-07-17 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04226326
The ClinicalTrials.gov registry entry for NCT04226326 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 4 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Chicago, which has 796 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Chronic Total Occlusion appearing as the primary indexed condition, and to 1 intervention - of which Directly measure microvascular function using direct coronary flow measurements is the first listed.
NCT04226326 reports 1 study location spanning 1 distinct geographic area - top geographies include Illinois.
Frequently Asked Questions
What is clinical trial NCT04226326 about?
NCT04226326 is a clinical study titled "Investigating the Utility of Remote Index of Microvascular Resistance in Patients With Chronic Total Occlusion". This is prospective cohort study in subjects with a planned percutaneous coronary intervention (PCI) of their chronic total occlusion (CTO). The study will enroll subjects who have been scheduled for a clinically-indicated cardiac catheterization, and will evaluate coronary microvascular function in...
What is the current status of trial NCT04226326?
This trial is currently completed. It is a NA study. The enrollment target is 4 participants. The study started on 2020-01-15. Estimated completion is 2023-07-17.
What conditions does trial NCT04226326 study?
This clinical trial studies the following conditions: Chronic Total Occlusion.
What interventions are being tested in trial NCT04226326?
The interventions under investigation include: Directly measure microvascular function using direct coronary flow measurements (OTHER).
Who is sponsoring clinical trial NCT04226326?
This trial is sponsored by University of Chicago, which has 796 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04226326 being conducted?
This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Chronic Total Occlusion
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.